Samsung Bioepis Initiates Phase 3 Clinical Trial for SB27, Proposed Biosimilar to Keytruda (Pembroli
资讯
2024-04-05
INCHEON,Korea,April05,2024(GLOBENEWSWIRE)-SamsungBioepisCo.,Ltd.todayannouncedtheinitiationofPhase3clinicaltrialforSB27,thecompany'sproposedbiosimilarreferencingKeytrudai ...